Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Lik Sprava ; (2): 99-106, 2013 Mar.
Artigo em Russo | MEDLINE | ID: mdl-24605619

RESUMO

Acute respiratory viral infections (ARVI) and influenza take a leading place in the structure of the general morbidity of the population in most countries of the world. Of etiotropic treatment of influenza and other ARVI include a wide spectrum of antiviral drugs, among which are the drugs with a restricted spectrum, basically used in influenza, and a general spectrum used in influenza and other ARVI as a prophylactic or therapeutic intention. At present time, there is a widespread antiviral drug umifenovir. On the mechanism of antiviral action it refers to the fusion inhibitors of the virus with the cell membrane. Antiviral activity in vitro umifenovir studied in several independent laboratories. Umifenovir active against respiratory viruses such as rhinovirus, adenovirus, influenza virus, parainfluenza, respiratory syncytial virus, coronavirus, including the causative agent of atypical pneumonia. There are a large number of studies that have shown clinical efficiency of umifenovir. In clinical studies of prophylactic and therapeutic efficiency of umifenovir attended by 12400 and 1400 persons relatively. An important role in the prevention and treatment of influenza and ARVI occupy modern nanotechnological products of natural origin such as anaferon, aflubin, oscillococcinum having antiviral, immunomodulatory, anti-inflammatory, disintoxicational and antipyretic activity.


Assuntos
Antivirais/uso terapêutico , Indóis/uso terapêutico , Influenza Humana/tratamento farmacológico , Doença Aguda , Antivirais/administração & dosagem , Ensaios Clínicos como Assunto , Humanos , Indóis/administração & dosagem , Influenza Humana/virologia , Infecções Respiratórias/tratamento farmacológico , Infecções Respiratórias/virologia , Resultado do Tratamento
3.
Vopr Pitan ; (4): 31-4, 1990.
Artigo em Russo | MEDLINE | ID: mdl-2244359

RESUMO

The influence of whey on the function of the stomach, biliary system and pancreas was studied in 112 children with chronic cholecystocholangitis. It has been established that whey possesses a choleretic property and normalizes the exocrine function of the pancreas. Whey can be recommended as a therapeutic agent or an additive to products for diet therapy in the combined treatment of chronic diseases of the biliary system, especially, with concomitant affection of the stomach and pancreas.


Assuntos
Fenômenos Fisiológicos da Nutrição Infantil , Colangite/dietoterapia , Colecistite/dietoterapia , Laticínios , Leite , Adolescente , Animais , Sistema Biliar/fisiopatologia , Criança , Colangite/fisiopatologia , Colecistite/fisiopatologia , Doença Crônica , Humanos , Pâncreas/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...